StockComparison Logo
vs

ACN vs GSK

Comparison between Accenture plc - Class A (ACN, Company) and GSK Plc (GSK, Company).

ACN is from the Technology sector, while GSK is from the Healthcare sector.

5-Year PerformanceGSK has outperformed ACN, delivering a return of +4.8% compared to -8.8%

ACN vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ACN
$105B
GSK
$104B
Max Drawdown
Winner
ACN
61.57%
GSK
64.03%
Sharpe Ratio
ACN
-1.60
Winner
GSK
1.03
5Y Beta
ACN
0.69
Winner
GSK
0.25
Industry
ACN
Information Technology Services
GSK
Drug Manufacturers - General
P/E Ratio
ACN
13.22
Winner
GSK
12.04
Forward P/E
Winner
ACN
11.19
GSK
11.38
PEG Ratio
ACN
4.47
Winner
GSK
0.10
Dividend Yield
Winner
ACN
3.80%
GSK
3.40%
5Y Dividends CAGR
Winner
ACN
18.50%
GSK
1.34%
5Y EPS CAGR
Winner
ACN
11.80%
GSK
4.65%
Debt to Equity
Winner
ACN
0.37%
GSK
106.74%
Free Cash Flow Yield
Winner
ACN
11.88%
GSK
8.07%
P/S Ratio
Winner
ACN
1.48
GSK
3.13
P/B Ratio
Winner
ACN
3.51
GSK
4.31

ACN vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
ACN
-2.02%
Winner
GSK
+5.15%
3M
ACN
-16.28%
Winner
GSK
-2.09%
6M
ACN
-38.89%
Winner
GSK
+7.79%
1Y
ACN
-45.97%
Winner
GSK
+33.69%
5Y(CAGR)
ACN
-8.82%
Winner
GSK
+4.81%
10Y(CAGR)
Winner
ACN
+5.26%
GSK
+5.21%
Max(CAGR)
Winner
ACN
+11.82%
GSK
+3.17%

ACN vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearACNGSK
2026-35.43%+6.95%
2025-21.43%+50.62%
2024+3.04%-6.27%
2023+31.88%+9.25%
2022-33.58%-32.73%
2021+63.63%+23.62%
2020+26.31%-17.52%
2019+51.66%+30.36%
2018-6.67%+9.29%
2017+34.11%-3.80%
2016+17.33%+1.52%
2015+20.17%+0.48%
2014+12.88%-14.73%
2013+21.90%+26.97%
2012+28.40%-0.75%
2011+11.72%+22.51%
2010+17.42%-3.72%
2009+25.61%+20.27%
2008-6.23%-21.93%
2007+0.03%-2.77%
2006+27.42%+6.93%
2005+10.79%+9.96%
2004+4.17%+5.08%
2003+41.43%+25.04%
2002-31.36%-22.83%
2001+77.46%-9.58%
2000N/A+5.67%
1999N/A-5.78%

ACN vs GSK Drawdown Comparison

The maximum drawdown for ACN was -59.20%, occurring on Oct 4, 2002. Recovery took 964 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current ACN drawdown is -57.13%. The current GSK drawdown is -13.24%.

RankACNGSK
#1-59.20%
Mar 11, 2002 - Jan 5, 2006
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-58.63%
Feb 5, 2025 - May 13, 2026
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-39.69%
Dec 29, 2021 - Feb 5, 2025
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-36.59%
Jul 23, 2007 - Dec 1, 2009
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-33.45%
Feb 19, 2020 - Jun 25, 2020
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-25.22%
Jul 7, 2011 - Mar 15, 2012
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-23.55%
Aug 1, 2001 - Oct 12, 2001
-18.61%
Feb 18, 2026 - Jun 2, 2026
#8-22.56%
Sep 21, 2018 - Mar 28, 2019
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-21.74%
Feb 27, 2006 - Oct 26, 2006
-10.52%
May 16, 2006 - Feb 13, 2007
#10-18.42%
Apr 23, 2010 - Oct 5, 2010
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-15.21%
Mar 26, 2012 - Sep 13, 2012
-8.45%
May 28, 2013 - Nov 1, 2013
#12-14.95%
Oct 28, 2015 - Mar 24, 2016
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-14.44%
May 28, 2013 - Dec 26, 2013
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-14.16%
Jan 10, 2002 - Feb 1, 2002
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-13.25%
Sep 2, 2020 - Nov 24, 2020
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between ACN and GSK is 0.74 which considered as a strong positive correlation - the stocks tend to move together.

0.74
-101

Dividend Comparison (2000 - 2026)

ACN vs GSK dividend yield comparison.

YearACNGSK
20261.97%1.69%
20252.26%3.42%
20241.52%4.60%
20231.33%3.75%
20221.51%5.47%
20210.87%4.99%
20201.26%5.59%
20191.07%4.35%
20181.98%5.65%
20171.66%5.83%
20161.97%6.86%
20152.03%5.93%
20142.18%6.20%
20132.12%4.51%
20122.23%5.70%
20112.11%4.83%
20101.70%5.10%
20091.81%4.39%
20083.05%5.74%
20071.17%4.09%
20060.95%3.29%
20051.04%3.03%
20040.00%3.38%
20030.00%2.77%
20020.00%3.10%
20010.00%1.54%
20000.00%4.57%

Select Stocks to Compare